‘Turning point in the fight against Alzheimer’s’ as drug found to slow disease

A new drug has been shown to reduce the rate of cognitive decline in Alzheimer’s patients by up to 35%. File Picture: iStock

A new drug has been hailed as a “turning point in the fight against Alzheimer’s” after it was found to slow the progression of the disease.

Donanemab was found to slow “clinical decline” by up to 35%, meaning that people with the disease could still go about performing day-to-day tasks including shopping, housekeeping, managing finances and taking medication.